Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Report for the period 1 January-30 June 2020

1 April– 30 June 2020 · Consolidated net sales amounted to TSEK 2 813 (6 279) · Net operating income amounted to TSEK -617 (1 666) · Operating profit amounted to TSEK -2 298 (-10 441) · Net profit for the quarter amounted to TSEK -14 028 (-18 366) · Earnings per share before and after dilution effects amounted to SEK -28,06 (-36,73) 1 January– 30 June 2020 · Consolidated net sales amounted to TSEK 5 491 (11 473) · Net operating income amounted to TSEK -2 452 (-715) · Operating profit amounted to TSEK -12 071 (-15 947) · Net profit for the period amounted to

Africa Energy Spuds Luiperd-1X Well Offshore South Africa

Vancouver, BC, August 28, 2020 /CNW/ - Africa Energy Corp. (TSX Venture: AFE) (Nasdaq First North: AEC) (“Africa Energy” or the “Company”), an oil and gas company with exploration assets offshore South Africa and Namibia, is pleased to announce spud of the Luiperd-1X well, the second exploration well on Block 11B/12B offshore South Africa following the Brulpadda discovery in February 2019. Jan Maier, Africa Energy’s VP Exploration, commented: “The Outeniqua Basin offshore South Africa remains an under-explored, world-class hydrocarbon province. The Luiperd-1X well will test the eastern

Ikano Bank AB (publ) Interim Report 30 June 2020

Work to transform the Bank continues “The transformation continues with full strength, and has been further accelerated due to Covid-19. The purpose is to radically transform the bank, to better serve our customers and improve cost-income ratio. This is done by further digitalising and streamlining the business, creating better growth opportunities with modern and internationally scalable systems, reducing cost and increasing customer satisfaction.   However, the combination of extensive investments in our transformation and the effect of a global pandemic affect our half-year result,

BioStock: Saniona strengthens US executive team with three industry veterans

Since American Rami Levin took over as new CEO for Saniona in January, the company has had the clear ambition to build a full-fledged organisation in the United States. The establishment of the head office took a big step forward with the appointment of three central positions, at the same time as pivotal clinical studies in two rare eating disorders are approaching. BioStock contacted the CEO for a comment on how the new competencies strengthen the company’s goal of reaching the market with the primary drug candidate Tesomet.Read the full interview with Rami Levin at biostock.se: https:/

Getinge new principal partner for the Foundation for Queen Silvia Children’s Hospital

Medical technology company Getinge is now principal partner for the Foundation for Queen Silvia Children’s Hospital, a fundraising organization that makes a difference for children and young people who are treated for both physical and mental illness at Sweden's largest children's hospital. Photo: Glenn T Unger The foundation, which was established in 2001, is a non-profit organization that raises funds from companies and private individuals to pay for things, environments, experiences and activities that bring joy and a better quality of life for children, young people and

Fast construction of wooden residential buildings in Linnanfältti

Wooden multi-storey apartment buildings in Linnanfältti, close to the centre of Turku, Finland are being built with Kerto[®] LVL-based elements. A residential building constructed from wooden elements can rise in less than half the time compared to a similar kind of concrete building. With Metsä Wood’s Kerto LVL-based elements (laminated veneer lumber) buildings are fast, light and green to construct. Four multi-storey wooden residential buildings in Linnanfältti are made of Kerto LVL-based wooden elements.  The project's developer is Kruunuasunnot and NCC is responsible for the

FREYR advances the development of its initial site for Norway ’ s first battery cell facility

FREYR continues to advance the development of Norway’s first lithium-ion battery cell (LIB) facility and are currently optimising the basis for the 2 GWh Fast Track production facility together with local site partner Mo Industrial Park (MIP). Today, the ongoing collaboration between FREYR and MIP was further formalised by the signing of a Memorandum of Understanding (MoU) for the planned Fast Track production facility site. The site is “plug and play” with all infrastructure ready and available area will furthermore be increased from 40.000 m2 to 70 000 m2. “Our ambition is to make

ONE HOME, ONE PLANET 2020: Sparking change together

All over the world, people want change and so does IKEA. Better, healthier, and more sustainable lives. A greener, fairer, and more accepting world. With a decade left to protect our planet from the worst effects of climate change, we need collaborative action.This is why Ingka Group has created ONE HOME, ONE PLANET 2020 (OHOP) , an action-orientated two-day virtual sustainability event on 2 and 3 September, to bring together nearly 300 purpose-driven doers and key influencers from different fields, who are full of ideas and solutions, to create a

Read original

OL3 EPR regular production of electricity starts in February 2022

Teollisuuden Voima Oyj (TVO) has received an updated re-baseline schedule on the commissioning of the OL3 EPR plant unit from the supplier Areva-Siemens consortium. According to the schedule fuel will be loaded into the reactor in March 2021, the unit will be connected to the grid in October of the same year, and regular electricity production starts in February 2022.Issues that have caused delays in the project schedule are slowly progressing system testing, technical problems that have been identified in tests, and the increase in the amount of maintenance work caused by project delay.

NENT Group expands UFC coverage to Iceland

· Viaplay now home to UFC in all five Nordic countries · More than 8% of Icelandic households already signed up to a Viaplay package · NENT Group has rights to show more than 50,000 hours of the world’s best live sporting action every year on its streaming services and TV channels Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company, has expanded its Nordic UFC rights to Iceland until the end of 2021. Starting this weekend, UFC fans in Iceland can follow all the high-impact action from the world’s premier mixed martial arts (MMA) organisation,

Ellevio AB Half Year Report January-June 2020

Key financials · The company welcomed circa 3,000 new customers during the first six months of the year, reaching approximately 965,000 customers at the end of the period · Net sales amounted to SEK 3,455 million (3,662) · Distributed electricity amounted to a total of 13.7 TWh (13.9) · Operating profit amounted to SEK 859 million (1,161) · Free cash flow totalled SEK 531 million (1,346) · Capital expenditure, amounted to 1,391 SEK million (1,266). The report comments on important aspects of the operations during the period, including the implications of the covid-19

SynAct Pharma Initiates RESOVIR: Scientific and clinical Collaboration to Explore AP1189 in Viral Infections

SynAct Pharma AB ("SynAct Pharma") hereby announces that the company together with Prof Mauro Teixeira, MD, PhD, Universidade Federal de Minas, Belo Horizonte, Brazil and Prof Mauro Perretti, PhD William Heavy Research Institute, Barts and the London School of Medicine, Queen Mary University, London, UK has established a scientific and clinical collaboration, RESOVIR (resolution in viral inflammation), aimed to investigate pharmacological promotion of inflammatory resolution as a novel approach to control viral infections. The first step of the collaboration will be to run an exploratory

Interim report, January - June 2020

Second quarter, April - June 2020 · Net Sales amounted to SEK 454.5 m (440.8), an increase of 3.1%. · EBITDA before items affecting comparability amounted to SEK 60.7 m (57.0), an increase of 6.4%. The EBITDA margin before items affecting comparability amounted to 13.4% (12.9%). · EBITDA amounted to SEK 56.6 m (53.1), an increase of 6.6%. The EBITDA margin amounted to 12.5% (12.0%). · Operating profit (EBIT) amounted to SEK 32.7 m (32.0), an increase of 2.0%. The operating margin amounted to 7.2% (7.3%). · Net profit for the quarter amounted to SEK 15.7 m (15.4), an

Fabege granted a land allocation permit at Sveaplan by the City of Stockholm

The Land Development Board (Exploateringsnämnden) decided at its meeting on 27 August 2020 to grant Fabege a land allocation permit at Sveaplan. A prerequisite for the creation of the development right, covering about 9,000 square metres, is that Sveaplan is redeveloped in accordance with the city’s plans for Östra Hagastaden.Fabege owns the well-known Wenner-Gren Center building and the three nearest buildings on Sveavägen. This allows a holistic perspective and co-utilisation of facilities by people using or working in the area. · “It is not often that newbuild opportunities arise

Registration Details for Immunovia’s Second Webinar in the Series on IMMray™ PanCan-d: Commercial Test Model Study & Update on Launch Activities

LUND, SWEDEN – Immunovia AB (publ) (“Immunovia”), today announced that the company will be hosting the second webinar in the series on Immunovia’s IMMray™ PanCan-d. This second webinar will cover the results of the Commercial Test Model Study (link to pr ) and updates on the launch activities. Event Details: Immunovia’s IMMray™ PanCan-d Webinar Series Webinar No. 2: Commercial Test Model Study &

Interim Report 2020-01-01 – 2020-06-30

The Board and Chief Executive Officer of Cereno Scientific AB here with present the Interim Report for the second quarter 2020. Summary of the Interim Report Cereno Scientific Group  Six months (1 January 2020 – 30 June 2020) · Net Sales were 0 SEK. · Loss after financial items was SEK -7 774 588. · Loss per share was SEK -0.19 before dilution and SEK -0,18after dilution*. · The equity/assets ratio was 94,9 %. Second quarter (1 April 2020 – 30 June 2020) · Net Sales were 0 SEK. · Loss after financial items was SEK -4 021 921. · Loss per share was SEK -

Proposal from the Nomination Committee to the Extraordinary General Meeting in Otello Corporation ASA to be held on 4 September 2020

STOCK EXCHANGE ANNOUNCEMENT   Se vedlagte fil for noe informasjon på norsk. (Oslo, Norway, 28 August 2020) On 14 August 2020, Otello Corporation ASA (“Otello”) announced that an extraordinary general meeting would be held on 4 September 2020 at the request Otello’s largest shareholder, Sand Grove Capital Management LLP (“Sand Grove”). Sand Grove has proposed significant changes to the board by replacing chairman André Christiansen and board member Birgit Midtbust with two new board members nominated by Sand Grove, Randel Freeman and Kathryn Baker. This is despite the fact that

Flowscape wins order for seven offices in the UK

A British customer has selected Flowscape Room and Desk Booking solution for seven offices in the UK.  Desk booking is an important part of the customers strategy for safe and controlled return to the office. The order value in the first year is 350,000 SEK and thereafter 175,000 SEK annually.“Our business in the UK is developing very positively and there is a great demand for digital solutions supporting and manage a safe return to the office. We are very happy that our new Covid-19 solution is so popular. This large installation has additional potential when the customer decides to open

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

Announcement no. 29 - 28 August 2020 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, Motortramp A/S continuously sells shares pro rata and the market is to be informed accordingly – see the attached file. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information: Martin Badsted, CFO, tel.: +45 3315 0451Anne-Louise Dam-Rasmussen, Head of Communications, tel.: +45 3273 0624

Interim Report 1 January to 30 June 2020

Summary of the interim reportFirst Half Year (1 January to 30 June 2020) · Operating revenue KSEK 0 (0) · Income after financial items KSEK -24 370 (-13 412) · Earnings per share -0,50 (-0,36) · Cash and cash equivalents as of June 30th KSEK 40 630 (23 872) · Equity ratio as of June 30th 88,3 (90,3) % Second quarter (1 April to 30 June 2020) · Operating revenue KSEK 0 (0) · Income after financial items KSEK -14 187 (-6 655) · Earnings per share -0,29 (-0,18) Significant events during the second quarter of 2020 · Dr Tara Heitner appointed new CEO ·

Q4  Year-end Report July 2019 – June 2020

Opening remarks The fiscal year 2019/2020 of Hamlet Pharma AB has been very successful. Positive results of our first double blind, placebo controlled clinical study were announced and we conclude that Alpha1H treatment shows efficacy in patients with bladder cancer. The patients did not develop drug-related side effects confirming the safety of Alpha1H. The results define Alpha1H as a drug candidate with significant potential in bladder cancer and other cancer indications.Significant research advances form the basis for continued clinical trials.  Based on significant therapeutic

There are no items matching the current filter
There are no more items matching the current filter
Back to top